P1.01-11 Named Patient Use Program for Afatinib in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers

Autor:	T.T. Chan, S. Wang, K. Park, Robert M. Lorence, S. Aggarwal, Agnieszka Cseh, Christina Raabe, J. Shih, R. Li, Virote Sriuranpong, S.-B. Kim, Yun-Hyeon Kim, C.-M. Tsai, Philippe Carrière, G-C. Chang, W. Lim, C.L.D. Lam, I. Wahid, Yi Ming Arthur Chen
Rok vydání:	2018
Předmět:	0301 basic medicine Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty business.industry Afatinib 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Prior Therapy 030220 oncology & carcinogenesis Internal medicine Medicine business medicine.drug
Zdroj:	Journal of Thoracic Oncology. 13:S463
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2018.08.567
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a41277433441d7a11dbd347a90b7226d https://doi.org/10.1016/j.jtho.2018.08.567 Zobrazit plný text záznamu